Referenced Citations Ahrn, B., et al., Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials
Prevalence, deaths and disability-adjusted-life-years (DALYs) due to type 2 diabetes and its attributable risk factors in 204 countries and territories, 1990-2019: results from the global burden of disease study 2019
Tirzepatide is administered as a once-weekly injection of tirzepatide delivered via the KwikPen device
A short intake questionnaire cannot replace a comprehensive medical assessment that includes health history review, medication reconciliation, laboratory evaluation, and cardiovascular risk screening
& Noble, W
Even in the UK's overcast weather, you should wear sun cream and stay hydrated